{"id":1787,"date":"2020-02-10T00:00:00","date_gmt":"2020-02-09T23:00:00","guid":{"rendered":"https:\/\/www.ship2b.org\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency"},"modified":"2025-02-08T01:12:45","modified_gmt":"2025-02-08T00:12:45","slug":"equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency","status":"publish","type":"post","link":"https:\/\/www.ship2b.org\/en\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/","title":{"rendered":"Equity4Good aprueba un follow-on en ADmit Therapeutics y Dental Residency"},"content":{"rendered":"<p><b>ADmit Therapeutics, Dental Residency y Visualfy<\/b><span style=\"font-weight: 400\">, startups invertidas por nuestro veh\u00edculo Equity4Good, abren rondas de inversi\u00f3n para impulsar sus respectivos proyectos. Nosotros ya hemos apostado por ellos, \u00bfnos acompa\u00f1as?\u00a0<\/span><\/p>\n<p><b>ADmit Therapeutics<\/b><span style=\"font-weight: 400\">, spin-off del Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge, est\u00e1 desarrollando un test de diagn\u00f3stico precoz para la enfermedad de Alzheimer basado en un an\u00e1lisis de sangre. En la ronda actual busca 400.000 euros que le ofrezca el presupuesto necesario para obtener el objetivo 2020 para la validaci\u00f3n cl\u00ednica. El plan de desarrollo contempla\u00a0el marcado CE en 2023 para poder comercializar un algoritmo predictivo y un software que proporcione el diagn\u00f3stico del paciente.\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">\u00c1mbito de actuaci\u00f3n: Salud \/ Alzheimer<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Ronda: 400.000 euros<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Inversi\u00f3n m\u00ednima: 675 euros<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">M\u00e1s informaci\u00f3n: <\/span><a href=\"blank\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400\">Capitall Cell<\/span><\/a><\/li>\n<\/ul>\n<p style=\"text-align: center\">\n<p><b>Dental Residency<\/b><span style=\"font-weight: 400\">, naci\u00f3 hace 5 a\u00f1os con el objetivo de dar respuesta a las necesidades odontol\u00f3gicas de la gente mayor a trav\u00e9s de una atenci\u00f3n adaptada y de calidad para todas las personas dependientes institucionalizadas en centros geri\u00e1tricos y de diversidad funcional de Espa\u00f1a. El objetivo de la ronda actual, en la que buscan 300.000 euros, es iniciar actividad en Pa\u00eds Vasco, as\u00ed como reforzar el equipo de ventas.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">\u00c1mbito de actuaci\u00f3n:\u00a0Salud dental \/ Dependencia<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Ronda:\u00a0300.000 euros<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Inversi\u00f3n m\u00ednima:\u00a01.000 euros<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">M\u00e1s informaci\u00f3n: <\/span><a href=\"blank\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400\">La Bolsa Social<\/span><\/a><\/li>\n<\/ul>\n<p style=\"text-align: center\">\n<p><span style=\"font-weight: 400\">En ADmit Therapeutic y Dental Residency haremos un <strong>follow-on desde nuestro veh\u00edculo de inversi\u00f3n Equity4Good.<\/strong><\/span><\/p>\n<p><span style=\"font-weight: 400\">Por su parte, <\/span><b>Visualfy<\/b><span style=\"font-weight: 400\"> ofrece soluciones para personas con p\u00e9rdida auditiva, recogiendo la informaci\u00f3n sonora de espacios p\u00fablicos y privados para adaptarla con se\u00f1ales visuales y sensoriales. Actualmente pone foco en VisualfyPlaces, que ofrece soluciones de accesibilidad para entornos de entidades como bibliotecas, museos, etc.\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">\u00c1mbito de actuaci\u00f3n: Tecnolog\u00edas inteligentes \/ P\u00e9rdida auditiva<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Ronda: 720.000 euros<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Inversi\u00f3n m\u00ednima: 10.000 euros<\/span><\/li>\n<li style=\"font-weight: 400\">M\u00e1s informaci\u00f3n: <a href=\"mailto:gsarrias@ship2b.org\" target=\"_blank\" rel=\"noopener noreferrer\">Env\u00eda un email<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>ADmit Therapeutics, Dental Residency y Visualfy, startups invertidas por nuestro veh\u00edculo Equity4Good, abren rondas de inversi\u00f3n para impulsar sus respectivos proyectos. Nosotros ya hemos apostado por ellos, \u00bfnos acompa\u00f1as?\u00a0 ADmit Therapeutics, spin-off del Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge, est\u00e1 desarrollando un test de diagn\u00f3stico precoz para la enfermedad de Alzheimer basado en un an\u00e1lisis &hellip; <a href=\"https:\/\/www.ship2b.org\/en\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/\">Read more<\/a><\/p>\n","protected":false},"author":7,"featured_media":1788,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[21],"tags":[187,188],"class_list":["post-1787","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ship2b","tag-equity4good","tag-impact-equity-bf"],"acf":[],"yoast_head":"<title>Equity4Good aprueba un follow-on en ADmit Therapeutics y Dental Residency - Ship2B Foundation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Equity4Good aprueba un follow-on en ADmit Therapeutics y Dental Residency - Ship2B Foundation\" \/>\n<meta property=\"og:description\" content=\"ADmit Therapeutics, Dental Residency y Visualfy, startups invertidas por nuestro veh\u00edculo Equity4Good, abren rondas de inversi\u00f3n para impulsar sus respectivos proyectos. Nosotros ya hemos apostado por ellos, \u00bfnos acompa\u00f1as?\u00a0 ADmit Therapeutics, spin-off del Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge, est\u00e1 desarrollando un test de diagn\u00f3stico precoz para la enfermedad de Alzheimer basado en un an\u00e1lisis &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/\" \/>\n<meta property=\"og:site_name\" content=\"Ship2B Foundation\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-09T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-08T00:12:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ship2b.org\/wp-content\/uploads\/2020\/05\/BLOG_ADMIT-DENTAL-VISUALFY.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"monolitdigital\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"monolitdigital\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/\",\"url\":\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/\",\"name\":\"Equity4Good aprueba un follow-on en ADmit Therapeutics y Dental Residency - Ship2B Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/www.ship2b.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ship2b.org\/wp-content\/uploads\/2020\/05\/BLOG_ADMIT-DENTAL-VISUALFY.jpg\",\"datePublished\":\"2020-02-09T23:00:00+00:00\",\"dateModified\":\"2025-02-08T00:12:45+00:00\",\"author\":{\"@id\":\"https:\/\/www.ship2b.org\/#\/schema\/person\/5e1e3cfe72b47ae1bcbc7b9d714051bb\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#primaryimage\",\"url\":\"https:\/\/www.ship2b.org\/wp-content\/uploads\/2020\/05\/BLOG_ADMIT-DENTAL-VISUALFY.jpg\",\"contentUrl\":\"https:\/\/www.ship2b.org\/wp-content\/uploads\/2020\/05\/BLOG_ADMIT-DENTAL-VISUALFY.jpg\",\"width\":800,\"height\":400,\"caption\":\"BLOG_ADMIT-DENTAL-VISUALFY\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.ship2b.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Equity4Good aprueba un follow-on en ADmit Therapeutics y Dental Residency\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ship2b.org\/#website\",\"url\":\"https:\/\/www.ship2b.org\/\",\"name\":\"Ship2B Foundation\",\"description\":\"Adventurers for a better world\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ship2b.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ship2b.org\/#\/schema\/person\/5e1e3cfe72b47ae1bcbc7b9d714051bb\",\"name\":\"monolitdigital\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ship2b.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/946a2b9f66f4160be08b4f9a06887503c98ef66c5b9b64ee89d92fc57ef7eb18?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/946a2b9f66f4160be08b4f9a06887503c98ef66c5b9b64ee89d92fc57ef7eb18?s=96&d=mm&r=g\",\"caption\":\"monolitdigital\"},\"url\":\"https:\/\/www.ship2b.org\/en\/actualidad\/author\/monolitdigital\/\"}]}<\/script>","yoast_head_json":{"title":"Equity4Good aprueba un follow-on en ADmit Therapeutics y Dental Residency - Ship2B Foundation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/","og_locale":"en_US","og_type":"article","og_title":"Equity4Good aprueba un follow-on en ADmit Therapeutics y Dental Residency - Ship2B Foundation","og_description":"ADmit Therapeutics, Dental Residency y Visualfy, startups invertidas por nuestro veh\u00edculo Equity4Good, abren rondas de inversi\u00f3n para impulsar sus respectivos proyectos. Nosotros ya hemos apostado por ellos, \u00bfnos acompa\u00f1as?\u00a0 ADmit Therapeutics, spin-off del Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge, est\u00e1 desarrollando un test de diagn\u00f3stico precoz para la enfermedad de Alzheimer basado en un an\u00e1lisis &hellip; Read more","og_url":"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/","og_site_name":"Ship2B Foundation","article_published_time":"2020-02-09T23:00:00+00:00","article_modified_time":"2025-02-08T00:12:45+00:00","og_image":[{"width":800,"height":400,"url":"https:\/\/www.ship2b.org\/wp-content\/uploads\/2020\/05\/BLOG_ADMIT-DENTAL-VISUALFY.jpg","type":"image\/jpeg"}],"author":"monolitdigital","twitter_card":"summary_large_image","twitter_misc":{"Written by":"monolitdigital","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/","url":"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/","name":"Equity4Good aprueba un follow-on en ADmit Therapeutics y Dental Residency - Ship2B Foundation","isPartOf":{"@id":"https:\/\/www.ship2b.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#primaryimage"},"image":{"@id":"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ship2b.org\/wp-content\/uploads\/2020\/05\/BLOG_ADMIT-DENTAL-VISUALFY.jpg","datePublished":"2020-02-09T23:00:00+00:00","dateModified":"2025-02-08T00:12:45+00:00","author":{"@id":"https:\/\/www.ship2b.org\/#\/schema\/person\/5e1e3cfe72b47ae1bcbc7b9d714051bb"},"breadcrumb":{"@id":"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#primaryimage","url":"https:\/\/www.ship2b.org\/wp-content\/uploads\/2020\/05\/BLOG_ADMIT-DENTAL-VISUALFY.jpg","contentUrl":"https:\/\/www.ship2b.org\/wp-content\/uploads\/2020\/05\/BLOG_ADMIT-DENTAL-VISUALFY.jpg","width":800,"height":400,"caption":"BLOG_ADMIT-DENTAL-VISUALFY"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ship2b.org\/actualidad\/equity4good-aprueba-un-follow-on-en-admit-therapeutics-y-dental-residency\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ship2b.org\/en\/"},{"@type":"ListItem","position":2,"name":"Equity4Good aprueba un follow-on en ADmit Therapeutics y Dental Residency"}]},{"@type":"WebSite","@id":"https:\/\/www.ship2b.org\/#website","url":"https:\/\/www.ship2b.org\/","name":"Ship2B Foundation","description":"Adventurers for a better world","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ship2b.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.ship2b.org\/#\/schema\/person\/5e1e3cfe72b47ae1bcbc7b9d714051bb","name":"monolitdigital","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ship2b.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/946a2b9f66f4160be08b4f9a06887503c98ef66c5b9b64ee89d92fc57ef7eb18?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/946a2b9f66f4160be08b4f9a06887503c98ef66c5b9b64ee89d92fc57ef7eb18?s=96&d=mm&r=g","caption":"monolitdigital"},"url":"https:\/\/www.ship2b.org\/en\/actualidad\/author\/monolitdigital\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts\/1787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/comments?post=1787"}],"version-history":[{"count":2,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts\/1787\/revisions"}],"predecessor-version":[{"id":10492,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts\/1787\/revisions\/10492"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/media\/1788"}],"wp:attachment":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/media?parent=1787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/categories?post=1787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/tags?post=1787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}